Case Report: Pembrolizumab-associated airway-predominant relapsing polychondritis with longitudinal CD8+ T-cell activation and bronchial stenting

Can Xia, Jie Chen, Xia Fang, Changwen Deng, Xiaoping Zhu, Shuang Ye, Runci Wang

Open source

DOI
10.3389/fimmu.2026.1999620
Published
2026-10-22
Container
Frontiers in Immunology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1999620,
  title = {Case Report: Pembrolizumab-associated airway-predominant relapsing polychondritis with longitudinal CD8+ T-cell activation and bronchial stenting},
  author = {Can Xia and Jie Chen and Xia Fang and Changwen Deng and Xiaoping Zhu and Shuang Ye and Runci Wang},
  year = {2026},
  journal = {Frontiers in Immunology},
  doi = {10.3389/fimmu.2026.1999620},
  url = {https://doi.org/10.3389/fimmu.2026.1999620}
}

RIS

TY  - JOUR
TI  - Case Report: Pembrolizumab-associated airway-predominant relapsing polychondritis with longitudinal CD8+ T-cell activation and bronchial stenting
AU  - Can Xia
AU  - Jie Chen
AU  - Xia Fang
AU  - Changwen Deng
AU  - Xiaoping Zhu
AU  - Shuang Ye
AU  - Runci Wang
PY  - 2026
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2026.1999620
UR  - https://doi.org/10.3389/fimmu.2026.1999620
ER  - 

APA

Xia, C., Chen, J., Fang, X., Deng, C., Zhu, X., Ye, S., & Wang, R. (2026). Case Report: Pembrolizumab-associated airway-predominant relapsing polychondritis with longitudinal CD8+ T-cell activation and bronchial stenting. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2026.1999620

Source records